CEPI, an innovative partnership between public, private, philanthropic, and civil organizations, focuses on developing vaccines for diseases like Ebola, Lassa virus, and COVID-19. With over 20 vaccine candidates in development, CEPI also invests in new technologies for rapid vaccine development against unknown pathogens. Their 5-year plan aims to compress vaccine development timelines, create a broadly protective COVID-19 vaccine, and build a library of vaccine candidates for known and unknown pathogens. CEPI's goal is to enable fair global access to vaccines through COVAX, a program that ensures equitable distribution.